Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
December 2002
Features
Pharmaceutical-Approval Update
Pharmaceutical-Approval Update
Dr. Goldenberg discusses new drugs that have been approved for the treatment of hepatic disease, hypertension, and type 2 diabetes.
Marvin M. Goldenberg, PhD
A Survey of Investigational Drug Services at Academic Health Centers
The authors review the status of resources and requirements at 85 academic health centers in the U.S.
Alan H. Mutnick, PharmD, John A. Armitstead, MS, Thomas W. Cooley, BS, Kenneth Rockwell, Jr., PharmD, MS, and Karl A. Matuszewski, MS, PharmD
Departments
Editorial
Beyond Buy-in
Editor-in-Chief David Nash examines Robert Kegan’s take on why people find it difficult to change.
David B. Nash, MD, MBA
Medication Errors
Optimizing the Use of Computer System Clinical Alerts
Drug-related adverse events can be reduced when computerized pharmacy system alerts are fine-tuned on a regular basis.
Matthew Grissinger
Drug News
New Drugs/Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Prescription Washington
Bush Administration Attempts to Speed Up Availability of Generic Drugs
Mr. Barlas addresses the government’s interest in accelerating the availability of generic drugs.
Stephen Barlas
Drug Forecast
Olmesartan Medoxomil for Hypertension: A Clinical Review
The authors review a new agent, olmesartan medoxomil, for the treatment of hypertension.
Daryl Norwood, PharmD, Evans Branch III, PharmD, Bridget Smith, MD, and Marlon Honeywell, PharmD
